Movatterモバイル変換

[0]ホーム
URL:

Jump to content
WikipediaThe Free Encyclopedia
Search

Biosplice Therapeutics

From Wikipedia, the free encyclopedia
American biopharmaceutical company
Biosplice Therapeutics
Company typePrivately held company
IndustryRegenerative medicine
Founded2008; 17 years ago (2008) inSan Diego, USA
FounderOsman Kibar
Faterenamed from Samumed
Headquarters
San Diego, USA
Websitewww.biosplice.com

Biosplice Therapeutics, Inc. (formerlySamumed, LLC) is a privatebiopharmaceutical company based inSan Diego, California.[1] It was founded in 2008 byOsman Kibar.[2]

Samumed's products in development target novel components of theWnt signaling pathway.[3][4][5] The company focuses on potential treatments for several diseases; itsosteoarthritis program is its most advanced.[4][6]

References

[edit]
  1. ^"Small-molecule therapeutics using Biosplice Therapeutics".Business Outreach. 2023-08-16. Retrieved2024-07-06.
  2. ^"Forbes Profile: Osman Kibar", "Forbes"
  3. ^Herper, Matthew."Cure Baldness? Heal Arthritis? Erase Wrinkles? An Unknown Billionaire's Quest To Reverse Aging", "Forbes", May 10, 2016
  4. ^abRamsey, Lydia."A $12 billion startup you've probably never heard wants to cure baldness and smooth out your wrinkles", "Business Insider", April 2, 2017
  5. ^Lee, Yoolim."Eternal Youth Is the Next Big Bet for Singapore Venture Capitalist", "Bloomberg", February 9, 2017
  6. ^Jackson, Mandy."ACR Notebook: Lilly's Baricitinib Differentiates On Pain, Ironwood's Duzallo Progress, Corbus Nears Phase III", "Informa Scrip", November 8, 2017"
Authority control databasesEdit this at Wikidata


Stub icon

This United States corporation or company article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Biosplice_Therapeutics&oldid=1281630539"
Categories:
Hidden categories:
[8]ページ先頭
©2009-2025 Movatter.jp